Ribosomal drug resistance in mycobacteria

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 59-67

  Sander, P ^a   Meier, A ^a   Bottger E C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; GENE MUTATION; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RIBOSOME; TUBERCULOSIS;

EID: 0029874191     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80205-1     Document Type: Conference Paper

References (73)

1. Allen, P.N. & Noller, H.F. (1989), Mutations in ribosomal proteins S4 and S12 influence the higher order structure of 16S ribosomal RNA. J. Mol. Biol., 208, 457-468.
2. Benveniste, R. & Davies, J. (1973), Mechanisms of antibiotic resistance in bacteria. Annu. Rev. Biochem., 42, 471-506.
3. Bercovier, H., Kafri, O. & Sela, S. (1986), Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome. Biochem. Biophys. Res. Commun., 136, 1136-1141.
4. Birge, E.A. & Kurland, C.G. (1969), Altered ribosomal protein in streptomycin-dependent Escherichia coli. Science, 166, 1282-1284.
5. Bloom, B.R. & Murray, C.J.L. (1992), Tuberculosis: commentary on a reemergent killer. Science, 257, 1055-1064.
6. Böttger, E.C. (1994), Resistance to drugs targeting protein synthesis in mycobacteria. Trends Microbiol., 2, 416-421.
7. Bohmann, K., Ruusala, T., Jelenc, P.C. & Kurland, C.G. (1984), Kinetic impairment of restrictive streptomycin-resistant ribosomes. Mol. Gen. Genet., 198, 90-99.
8. Bonnet, E., Debat-Zoguerek, D., Petit, N., Ravaux, I. & Gallais, H. (1994), Clarithromycin: a potent agent against infections due to Mycobacterium marinum. Clin. Infect. Dis., 18, 664-666.
9. Brouadlon, F., Donner, D. & Kurland, G.G. (1983), Codon-specific missense errors in vivo. EMBO J., 2, 1351-1360.
10. Brown, B.A., Wallace, R.J., Jr. & Onyi, G.O. (1992a), Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob. Agents Chemother., 36, 1987-1990.
11. Brown, B.A., Wallace, Jr., R.J., Onyi, G.O., de Rosas, V. & Wallace III, R.J. (1992b), Activities of four macrolides, including clarithromycin against Mycobacterium fortuitum, Mycobacterium chelonae and M. chelonae-like organisms. Antimicrob. Agents Chemother., 36, 180-184.
12. Chaisson, R.E., Benson, C.A., Dube, M.P., Heifets, L.B., Korvick, J.A., Elkin, S., Smith, T., Craft, J.C., Sattler, F.R. & the AIDS Clinical Trials Group Protocol 157 Study Team (1994), Clarithromycin therapy for bacteremia in Mycobacterium avium complex disease. Ann. Intern. Med., 121, 905-911.
13. Chan, G.P., Garcia-Ignacio, B.Y., Chavez, U.E., Livelo, J.B., Jemenez, C.L., Parilla, M.L.R. & Franzblau, S.G. (1994), Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob. Agents Chemother., 38, 515-517.
14. Chittum, H.S. & Champney, W.S. (1994), Ribosomal protein sequence changes in erythromycin-resistant mutants of Escherichia coli. J. Bacteriol., 176, 6192-6198.
15. Cundliffe, E. (1981), Antibiotic inhibitors of ribosome function, in "The molecular basis of antibiotic action". (Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H., and Waring, J.M. (eds.) (pp. 402-547) John Wiley and Sons, New York.
16. Dautzenberg, B., Saint Marc, T., Meyohas, M.C., Eliaszewitch, M., Haniez, F., Rogues, A.M., De Wit, S., Cotte, L., Chauvin, J.P. & Grosset, J. (1993), Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch. Intern. Med., 153, 368-372.
17. Dautzenberg, B., Truffot, C., Legris, S., Meyohas, M.-C., Berlic, H.C., Mercat, A., Chevret, S. & Grosset, J. (1991), Activity of clarithromycin against Mycobacterium avium infections in patients with the acquired immune deficiency syndrome. Am. Rev. Respir. Dis., 144, 564-569.
18. Douglas, J. & Steyn, L.M. (1993), A ribosomal gene mutation in streptomycin-resistant Mycobacterium tuberculosis. J. Infect. Dis., 167, 1505-1506.
19. Etzold, T., Fritz, C.C., Schell, J. & Schreier, P.H. (1987), A point mutation in the chloroplast 16S rRNA gene of a streptomycin-resistant Nicotiana tabacum. FEBS Lett., 219, 343-346.
20. Finken, M., Kirschner, P., Meier, A. & Böttger, B.C. (1993), Molecular basis of streptomycin in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol., 9, 1239-1246.
21. Franck, N., Cabic, A., Villette, B., Armor, B., Lessana-Leibowitch, M. & Escande, J.P. (1993), Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J. Am. Acad. Dermatol., 28, 1019-1021.
22. Frieden, T.R., Sterling, T., Pablos-Mendez, A., Kilburn, J.O., Cauthen, G.M. & Dooley, S.W. (1993), The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med., 328, 521-527.
23. Fromm, H., Galun, E. & Edelman, M. (1989), A novel site for streptomycin resistance in the "530 loop" of chloroplast 16S ribosomal RNA. Plant. Mol. Biol., 12, 499-505.
24. Funatsu, G. & Wittmann, H.G. (1972), Ribosomal proteins. Location of amino-acid replacements in protein S12 isolated from Escherichia coli mutants resistant to streptomycin. J. Mol. Biol., 68, 547-550.
25. Gauthier, A., Turmel, M. & Lemieux, C. (1988), Mapping of chloroplast mutations conferring resistance to antibiotics in Chlamydomonas: evidence for a novel site of streptomycin resistance in the small subunit rRNA. Mol. Gen. Gent., 214, 192-197.
26. Gutell, R.R., Weiser, B., Woese, C.R. & Noller, H.F. (1988), Comparative anatomy of 16S-like ribosomal RNA. Progr. Nucleic Acids Res., 32, 155-216.
27. Harris, E.H., Barkhart, B.D., Gillhamm, N.W. & Boynton, J.E. (1989), Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: correlation of genetic and physical maps of the chloroplast genome. Genetics, 123, 281-292.
28. Heifets, L., Mor, N. & Vanderkolk, J. (1993), Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob. Agents Chemother., 37, 2364-2370.
29. Heym, B., Honoré, N., Truffot-Pernot, C., Banerjee, A., Schurra, C., Jacobs, W.R. & van Embden, J.D.A. (1994), Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet, 344, 293-298.
30. Hoffner, S.E., Svenson, S.B. & Källenius, G. (1987), Synergistic effects of antimycobacterial drugs on Mycobacterium avium complex determined radiometrically in liquid medium. Eur. J. Clin. Microbiol. Infect. Dis., 6, 530-535.
31. Honoré, N., Marchal, G. & Cole, S.T. (1995), Novel mutation in 16S rRNA associated with streptomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 39, 769-770.
32. Husson, R.N., Rors, L.A., Sardelli, S., Inderlied, C.B., Venzon, D., Lewis, L.L., Woods, L., Conville, P.S., Witelesky, F.G. & Pizzo, P.A. (1993), Orally administered clarithromycin for the treatment of systemic Mycobacterium complex infection in children with acquired immunodeficiency syndrome. J. Pediatr., 124, 807-814.
33. Inderlied, C.B. & Salfinger, M. (1995), Antimicrobial agents and susceptibility tests: mycobacteria, in "Manual of clinical microbiology, 6th ed." (P.M. Murray, E.J./ Baron, M.A. Pfaller, F.C. Tenover and R.Y. Yolken) (pp. 1385-1404). American Society for Microbiology Press, Washington, D.C.
34. Ishida, H., Fuzimara, H., Kaibori, Y., Horiuchi, T., Sato, K. & Osada, Y. (1995), Choices of multidrug resistance gene pgrA from Proteus vulgaris. Antimicrob. Agents Chemother., 39, 452-457.
35. Kenney, T.J. & Churchward, G. (1994), Cloning and sequence analysis of the rpsL and rpsG genes in Mycobacterium smegmatis and characterization of mutations causing resistance to streptomycin. J. Bacteriol., 176, 6153-6156.
36. Leclerq, R. & Courvalin, P. (1991a), Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother., 35, 1267-1272.
37. Leclerq, R. & Courvalin, P. (1991b), Intrinsic and unusual resistance to macrolide, lincosamide and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother., 35, 1273-1276.
38. Lederberg, J. (1951), Streptomycin resistance: a genetically recessive mutation. J. Bacteriol., 61, 549-554.
39. Martin, C., Ranes, M. & Gicquel, B. (1990), Plasmids, antibiotic resistance and mobile genetic elements in mycobacteria. in "Molecular biology of the mycobacteria" (pp. 121-138) Surrey University Press/Academic Press, Guilford, United Kingdom, J. McFadden (ed.).
40. Medical Research Council (1948), Streptomycin treatment of pulmonary tuberculosis. Br. Med. J., 4, 769-782.
41. Medical Research Council (1952), The treatment of pulmonary tuberculosis with isoniazid. Br. Med. J., 2, 735-746.
42. Meier, A., Kirschner, P., Bange, F.-C., Vogel, U. & Böttger, E.C. (1994a), Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob. Agents Chemother., 38, 228-233.
43. Meier, A., Kirschner, P., Springer, B., Steingrube, V.A., Brown, B.A., Wallace Jr., R.J. & Böttger, E.C. (1994b), Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother., 38, 381-384.
44. Meier, A., Wallace, R.J., Brown, B.A., Sander, P., Heifets, L. & Böttger, E.C. (1995), Molecular mechanisms of resistance to clarithromycin in Mycobacterium avium-intracellulare complex. 95th General Meeting of the American Society for Microbiology, Washington, D.C.
45. Moazed, D. & Noller, H.F. (1987), Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (Lond.), 327, 389-394.
46. Monno, L., Angarano, G., Carbonara, S., Coppola, S., Costa, D., Quarto, M., and Pastore, G. (1994), Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet, 337, 852.
47. Montandon, P.E., Nicolas, P., Schürmann, P. & Stuttz, E. (1985), Streptomycin resistance of Euglena gracilis chloroplasts: identification of a point mutation in the 16S rRNA gene in an invariant position. Nucleic Acids Res., 13, 4299-4310.
48. Morris, S., Bai, G.H., Suffys, P., Portillo-Gomez, L., Fairchok, M. & Rouse, D. (1995), Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis., 171, 954-960.
49. Nair, J., Rouse, D.A., Bai, G.H. & Morris, S.L. (1993), The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol. Microbiol., 10, 521-527.
50. Nightingale, S.D., Byrd, L.T., Southern, P.M., Jokusch, J.D., Cal, S.X. & Wynne, B.A. (1992), Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J. Infect. Dis., 165, 1082-1085.
51. Noller, H.F., Hoffarth, V. & Zimniak, L. (1992), Unusual resistance of peptidyltransferase to protein extraction procedures. Science, 256, 1416-1419.
52. Noller, H.F., Moazed, D., Stern, S., Powers, T., Allen, P.N., Robertson, J.M., Weiser, B. & Triman, K. (1990), Structure of rRNA and its functional interactions in translation, in "The ribosome. Structure, function and evolution". (Triman, K., Morre, P.B., Schlessinger, D. and Warner, J.R. (eds)) (pp. 73-92). American Society for Microbiology, Washington, D.C.
53. Norman, E., Dellagostin, O.A., McFadden, J. & Dale, J.W. (1995), Gene replacement by homologous recombination in Mycobacterium bovis BCG. Mol. Microbiol., 16, 755-760.
54. Pestka, S. (1977), Inhibitors of protein synthesis in "Molecular mechanisms of protein biosynthesis" (Weissbach, H., and Pestka, S. (eds.)) (pp. 467-553) Academic Press, N.Y.
55. Pleij, C.W.A., Rietveld, K. & Bosch, L. (1985), A new principle of RNA folding based on pseudoknotting. Nucleic Acids Res., 13, 1717-1731.
56. Powers, T. & Noller, H.F. (1991), A functional pseudoknot in 16S ribosomal RNA. EMBO J., 10, 2203-2214.
57. Rastogi, N., Goh, K.S. & Bryskier, A. (1994), Activities of roxythromycin used alone and in combination with ethambutol, rifampin, amikacin, efloxacin and clofazimine against Mycobacterium avium complex. Antimicrob. Agents Chemother., 38, 1433-1438.
58. Ruf, B., Schürmann, D., Mauch, J., Jantake, G., Fehrenbach, F.J. & Pohle, H.D. (1992), Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. Infection, 20, 267-272.
59. Ruusala, T., Anderson, D., Ehrenbeg, M. & Kurland, C.G. (1984), Hyper-accurate ribosomes inhibit growth. EMBO J., 3, 2575-2580.
60. Ruusala, T. & Kurland, G.C. (1984), Streptomycin preferentially perturbs ribosomal proofreading. Mol. Gen. Genet., 198, 100-104.
61. Sander, P., Meier, A. & Böttger, E.C. (1995), rpsL, a dominant selectable marker for gene replacement in mycobacteria. Mol. Microbiol., 16, 991-1000.
62. Seoane, A.S. & Levy, S.B. (1995), Identification of new genes regulated by the marRAB operon in Escherichia coli. J. Bacteriol., 177, 530-535.
63. Shaila, M.S., Gopinathan, K.P. & Ramakrishnan, T. (1973), Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin-susceptible and -resistant strains. Antimicrob. Agents Chemother., 4, 205-213.
64. Sor, F. & Fukuhara, H. (1982), Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large subunit ribosomal RNA in yeast. Nucleic Acids Res., 10, 6571-6577.
65. Stern, S., Powers, T., Changchien, L.M. & Noller, H.F. (1988), Interaction of ribosomal proteins S5, S6, S11, S12, S18 and S21 with 16S rRNA. J. Mol. Biol., 201, 683-695.
66. Takata, R., Osawa, S., Tanaka, K., Teraoka, H. & Tamaki, M. (1970), Genetic studies of the ribosomal proteins in Escherichia coli. - V. Mapping of erythromycin resistance mutations which lead to alterations of a 50S ribosomal protein component. Mol. Gen. Genet., 109, 123-130.
67. Wallace, R.J., Jr., Brown, B.A., Griffith, D.E., Girard, W.M., Murphy, D.T., Onyi, G.O., Steingrube, V.A. & Mazurek, G.H. (1994), Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am. J. Respir. Crit. Care Med., 149, 1335-1341.
68. Wallace, R.J., Jr., Hull, S.I., Bobdy, D.G., Price, K.E., Swenson, J.M., Steele, L.C., & Christensen, L. (1985), Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonae. Am. Rev. Respir. Dis., 132, 409-416.
69. Wallace, R.J., Jr., Tanner, D., Brennan, R.J. & Brown, B.A. (1993), Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann. Intern. Med., 119, 482-486.
70. Wittmann, H.G., Stuffier, G., Apirion, D., Rosen, L., Tanaka, K., Tamaki, M., Takata, R., Deko, S., Otaka, E. & Osawa, S. (1973), Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol. Gen. Genet., 127, 175-189.
71. Woese, C.R., Fox, G.E., Zablen, L., Uchida, T., Bonen, K. Pechmann, K., Lewis, B.J. & Stahl, D. (1975), Conservation of primary structure in 16S ribosomal RNA. Nature (Lond.), 254, 83-86.
72. Woese, C.R. & Gutell, R.R. (1989), Evidence for several higher order structural elements in ribosomal RNA. Proc. Natl. Acad. Sci. USA, 86, 3119-3122.
73. Young, L.S., Wivicott, L., Wu, M., Kolonoski, P., Balan, R. & Inderlied, C.B. (1991), Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet, 138, 1107-1109.